Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO). Such investors are...
-
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GSI...
-
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Oddity Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD). Such investors are advised...
-
$615 Million Acquisition of the Covelya Group Will Be Partially Financed Through a $350 Million Public Offering of Subscription Receipts Preliminary 2025 Year-End Results and Stand-Alone 2026...
-
New York City, March 03, 2026 (GLOBE NEWSWIRE) -- Rivermate, a global Employer of Record and international payroll platform, announced today the expansion of its multi-country Employer of Record...
-
Los Angeles, March 03, 2026 (GLOBE NEWSWIRE) -- Dave Announces Proposed Offering of Convertible Notes Company plans to enter into capped call transactions and repurchase shares of its common...
-
PHOENIX, March 03, 2026 (GLOBE NEWSWIRE) -- Fold Holdings, Inc. (NASDAQ: FLD) (“Fold”), a bitcoin financial services company making it easy for individuals and businesses to earn, save, and spend...
-
Smithfield Foods to Announce Fourth Quarter and Full Year Fiscal 2025 Results on March 24, 2026
-
Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appealIf the $1.3 billion payment is realized,...
-
Spin-off of biopharma operations into a public company to be called “First Tracks Biotherapeutics” on track for Q2 2026, potentially as early as late-AprilPhase 1b enrollment ongoing in celiac disease...